View Older Stories View More Recent Stories
-
Moomoo and the New York Mets Enter Second Year of Strategic Partnership to Continue Enhancing the Fan Experience
-
Citigroup (C) Said To Weigh Buying US Regional Bank - Bloomberg
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Unilever shareholders to get majority stake in potential McCormick food deal, sources say
-
Form 424B2 CITIGROUP INC
-
Cities Face Legal Risk Without ADA Compliant Video Access
-
Form 424B2 CITIGROUP INC
-
Citi Upgrades Bilibili (BILI) to Buy
-
Emerging economies' record debt spree slumps into a freeze as Iran war rocks markets
-
CrossCountry Mortgage to acquire TWO for $10.80 per share in cash
-
TWO and CrossCountry Mortgage Announce Definitive Merger Agreement
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citi Upgrades Brown Forman (BF-B) to Neutral
-
Zenas BioPharma prices $300 million dual offering of notes and stock
-
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million
-
China banks outperform broader market after news of shareholding rule changes
-
UK GfK consumer sentiment drops to 11-month low on Iran war worries
-
Form 4 Citi Trends Inc For: Mar 25 Filed by: Heath David A
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form SCHEDULE 13G/A CITIGROUP INC Filed by: VANGUARD GROUP INC

